Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-075363
Filing Date
2015-10-13
Accepted
2015-10-13 21:12:15
Documents
2
Period of Report
2015-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2205
2 POA DOCUMENT poa.txt EX-24.3_609901 2611
  Complete submission text file 0001209191-15-075363.txt   6389
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1522 217TH PLACE SE SUITE 100 BOTHELL WA 98021
Business Address
Clendeninn Neil James (Reporting) CIK: 0001442443 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 151157071